From fintech giants to AI powerhouses, some of the world’s most valuable private companies are eyeing the public markets. Here’s what’s on the horizon.
After a turbulent stretch for public offerings that saw the IPO window narrow dramatically in 2022 and only partially reopen in the years since, 2026 is shaping up to be the year the floodgates may finally swing wide. A constellation of factors — stabilizing interest rates, renewed investor appetite for growth, and a backlog of mature private companies — is creating what many analysts consider the most promising environment for initial public offerings in half a decade.
The pipeline is formidable. Several companies valued in the tens of billions of dollars have been operating as private entities far longer than is typical, amassing the kind of revenue, user base, and operational maturity that public market investors crave. The question for many of them is no longer if they will go public, but when.
“We haven’t seen a backlog of IPO-ready companies this deep since the post-2008 recovery. The pressure to provide liquidity to early investors is immense.” — Market Analysts
THE COMPANIES EVERYONE IS WATCHING
While no IPO is confirmed until the S-1 is filed with the SEC, a handful of companies have dominated the speculation — and for good reason. These are firms with proven business models, massive scale, and the kind of name recognition that can drive outsized demand on listing day.
STRIPE
Fintech · Payments Infrastructure
Est. Valuation $50B+
Perhaps no company has been the subject of more IPO speculation over the past five years. Stripe, the payments infrastructure company founded by Irish brothers Patrick and John Collison, processes hundreds of billions of dollars in transactions annually for businesses ranging from startups to Fortune 500 enterprises. Having raised at a peak valuation of $95 billion before accepting a lower internal valuation, Stripe has reportedly been weighing a direct listing or traditional IPO as it looks to provide liquidity for employees and early investors.
DATABRICKS
Artificial Intelligence · Data Analytics
Est. Valuation $40B+
The AI boom has been kind to Databricks. The San Francisco–based data and artificial intelligence platform has become essential infrastructure for enterprises building machine learning models at scale. With annual recurring revenue reportedly surpassing $2 billion and growing rapidly, Databricks sits at the intersection of two of the market’s most powerful themes: enterprise software and AI. Its IPO would be one of the most closely watched in the technology sector.
KLARNA
Fintech · Consumer Finance · Buy Now, Pay Later
Major European Fintech
The Swedish buy-now-pay-later pioneer has undergone a remarkable transformation. After seeing its valuation slashed during the 2022 downturn, Klarna embarked on an aggressive cost restructuring — including leveraging AI to replace customer service functions — and returned to profitability. A Klarna IPO, likely on a U.S. exchange, would be one of the most significant European technology listings in years and a test of whether the BNPL model can command premium public market multiples.
SPACEX
Aerospace · Space Launch · Satellite Internet
Est. Valuation $200B+
Elon Musk’s rocket and satellite company is arguably the most valuable private company in the world, with a valuation that has soared past $200 billion in secondary market transactions. SpaceX operates two transformative businesses: its launch division, which has become the dominant provider of orbital rocket services globally, and Starlink, its rapidly growing satellite internet constellation that is already generating billions in revenue. While Musk has historically resisted taking SpaceX public, speculation has intensified that Starlink could be spun off as a separate publicly traded entity — giving investors access to one of the most compelling infrastructure plays of the decade without exposing the parent company’s more experimental ventures to public market scrutiny.
MEDLINE INDUSTRIES
Healthcare · Medical Supply Distribution
Est. Valuation $30B+
Not every anticipated IPO comes from Silicon Valley. Medline, the Illinois-based medical supply manufacturer and distributor, is one of the largest privately held companies in America. Backed by a consortium of private equity firms, Medline serves health systems and hospitals across the country. A public offering would give investors rare access to a dominant player in healthcare logistics — a sector that proved its essential nature during the pandemic.
PLAID
Fintech · API Infrastructure · Data Connectivity
Financial Data Platform
Plaid became a household name — at least in fintech circles — when Visa’s $5.3 billion acquisition bid was blocked by the DOJ on antitrust grounds in 2021. Since then, the company has continued to grow as the connective tissue linking consumer bank accounts to thousands of financial applications. With open banking regulations expanding globally, Plaid’s market opportunity has only widened, making an IPO a logical next chapter.
NAVAN
Enterprise SaaS · Travel & Expense Management
Corporate Travel Leader
Formerly known as TripActions, Navan has built a fast-growing platform that combines corporate travel booking with expense management. As business travel has rebounded and companies seek consolidated tools to manage costs, Navan has positioned itself as a modern alternative to legacy players. A public listing would put it in direct competition with publicly traded incumbents — and give investors a way to bet on the future of enterprise travel technology.
A WORD OF CAUTION FOR IPO INVESTORS
The excitement surrounding a wave of high-profile IPOs is understandable. But seasoned investors know that initial public offerings come with a unique set of risks that don’t apply to established public companies. The history of IPOs is littered with companies that soared on day one and languished for months — or years — afterward.
Before committing capital to any new listing, consider the following principles that separate disciplined investors from those caught up in the hype cycle.
ESSENTIAL PRECAUTIONS FOR IPO INVESTORS
1. Study the S-1 Filing — Not the Headlines
The prospectus filed with the SEC is the single most important document for any IPO investor. It contains the company’s actual financial performance, risk factors, executive compensation, and how proceeds will be used. Headlines and analyst chatter are no substitute for reading the primary source material.
2. Understand the Lock-Up Period Dynamics
Company insiders and early investors are typically barred from selling shares for 90 to 180 days after the IPO. When that lock-up window expires, a surge of selling pressure can depress the stock price significantly. Many savvy investors prefer to wait until after the lock-up period before establishing a position.
3. Resist the First-Day Frenzy
IPO “pops” — where shares surge 30%, 50%, or more on the first day of trading — are exciting to watch but dangerous to chase. That initial price spike is often driven by limited float and speculative demand, not fundamentals. Research shows that many IPOs underperform the broader market in their first year of trading.
4. Scrutinize the Valuation Against Fundamentals
A great company is not always a great investment. Compare the IPO valuation to revenue multiples, growth rates, and profitability metrics of comparable public companies. If the offering price already bakes in years of future growth, the margin of safety may be dangerously thin.
5. Maintain Position Sizing Discipline
No matter how compelling the story, a single IPO should represent only a modest allocation within a diversified portfolio. Newly public companies carry elevated uncertainty — limited trading history, unproven public market governance, and the potential for volatile earnings revisions.
6. Evaluate the Underwriting Syndicate
The reputation of the lead underwriters matters. Top-tier investment banks conduct rigorous due diligence and tend to bring higher-quality companies to market. While not a guarantee of success, the caliber of the underwriting team is a meaningful signal about institutional confidence in the offering.
The 2026 IPO class has the potential to be one of the most consequential in recent memory. But potential and performance are two very different things. For investors willing to do the work — reading filings, assessing valuations, and exercising patience — the opportunities could be substantial. For those swept up in the narrative without doing their due diligence, the risks are equally real.
As always, the best investors are the ones who let discipline, not excitement, guide their decisions.
DISCLAIMER: This article is for informational and educational purposes only and does not constitute financial advice, a recommendation, or a solicitation to buy or sell any securities. IPO details discussed are based on publicly available information and market speculation — none of the listings mentioned have been confirmed. Always consult with a qualified financial advisor before making investment decisions.